Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial

PURPOSE: Single-cycle melphalan 200 mg/m(2) and autologous hematopoietic cell transplantation (AHCT) followed by lenalidomide (len) maintenance have improved progression-free survival (PFS) and overall survival (OS) for transplantation-eligible patients with multiple myeloma (MM). We designed a pros...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Stadtmauer, Edward A., Pasquini, Marcelo C., Blackwell, Beth, Hari, Parameswaran, Bashey, Asad, Devine, Steven, Efebera, Yvonne, Ganguly, Siddharta, Gasparetto, Cristina, Geller, Nancy, Horowitz, Mary M., Koreth, John, Knust, Kristin, Landau, Heather, Brunstein, Claudio, McCarthy, Philip, Nelson, Courtney, Qazilbash, Muzaffar H., Shah, Nina, Vesole, David H., Vij, Ravi, Vogl, Dan T., Giralt, Sergio, Somlo, George, Krishnan, Amrita
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2019
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553842/
https://ncbi.nlm.nih.gov/pubmed/30653422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00685
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker